Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan

Journal of Infectious Diseases

Volumn 175, Issue 2 SUPPL., 1997, Pages

  Reichler, Mary R ^a   Kharabsheh, Sa'ad ^c   Rhodes, Philip ^c   Otoum, Haider ^c   Bloch, Samir ^c   Majid, Mazen Abdel ^c   Pallatisch, Mark A ^c   Patriarca, Peter A ^b   Cochi, Stephen L ^c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; ORAL POLIOMYELITIS VACCINE;

ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CHILD; DOSE RESPONSE; HEALTH PROGRAM; HUMAN; IMMUNE STATUS; IMMUNOGENICITY; INFANT; JORDAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POLIOMYELITIS; PRIORITY JOURNAL; SEROCONVERSION; SEROPREVALENCE; VACCINATION; VIRUS TYPING;

EID: 0031028369     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/175.supplement_1.s198     Document Type: Article

References (13)

1. Hull HF, Ward NA, Hull BP, Milstien JB, de Quadros C. Paralytic poliomyelitis: seasoned strategies, disappearing disease. Lancet 1994; 343: 1331-7.
2. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis, 1988-1991. MMWR Morb Mortal Wkly Rep 1993; 42:486-7, 493-5.
3. Centers for Disease Control and Prevention. Progress toward global eradication of poliomyelitis, 1988-1993. MMWR Morb Mortal Wkly Rep 1994; 43:499-503.
4. de Quadros CA, Andrus JK, Olivé JM, de Macedo CG, Henderson DA. Polio eradication from the Western Hemisphere. Annu Rev Public Health 1992; 13:239-52.
5. Patriarca PA, Linkins RW, Sutler RW, Orenstein WO. Optimal schedule for the administration of oral poliovirus vaccine. In: Kurstak E, ed. Measles and poliomyelitis. Vaccines, immunization, and control. Vienna: Springer Verlag, 1993:303-13.
6. World Health Organization Collaborative Study Group on Oral Poliovirus Vaccine. Factors affecting the immunogenicity of oral poliovirus vaccine: a prospective evaluation in Brazil and the Gambia. J Infect Dis 1995; 171:1097-106.
7. Richardson G, Linkins R, Eames M, et al. Immunogenicity of oral poliovirus vaccine administered in mass campaigns versus routine immunization programs. Bull World Health Organ 1995; 73:769-77.
8. Patriarca PA, Wright PF, John TJ. Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. Rev Infect Dis 1991; 13:926-39.
9. John TJ, Jayabal P. Oral polio vaccination of children in the tropics. I. The poor seroconversion rates and the absence of viral interference. Am J Epidemiol 1972; 96; 263-9.
10. Munube GWR, Mutanda LN. Seroepidemiology of poliovirus and efficacy of oral poliovirus immunization in rural Uganda children. East Afr Med J 1974; 1:75-81.
11. Triki H, Arrouji A, Dellagi K. La poliomyelite anterieure aigue situation en Tunisie en 1991-1992. Arch Inst Pasteur Tunis 1992; 69:21-7.
12. Mauler R, Gruschkau H. On stability of oral poliovirus vaccines. Dev Biol Stand 1978; 41:267-70.
13. De-Xiang D, Xi-Min H, Wan-Jun L, et al. Immunization of neonates with trivalent oral poliomyelitis vaccine (Sabin). Bull World Health Organ 1986; 64:853-60.